DCM
DMK

DAFNA Capital Management’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

DAFNA Capital Management’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-349
Closed -$127K – 77
2017
Q3 		$127K Hold
349
– – 0.08% 68
2017
Q2 		$127K Sell
349
-80
-19% -$24K 0.09% 72
2017
Q1 		$128K Buy
+429
New +$108K 0.11% 68
2014
Q2 		– Sell
-1,786
Closed -$795K – 50
2014
Q1 		$795K Hold
1,786
– – 0.68% 29
2013
Q4 		$799K Buy
+1,786
New +$783K 0.82% 28

Other funds holding DMK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BRF
B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
LCM
Leisure Capital Management Costa Mesa, California $286M AUM 26.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

DAFNA Capital Management's DMK Position: Q4 2017 in Review

DAFNA Capital Management sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q4 2017, closing a stake of 349 shares — an estimated $127K sold.

DAFNA Capital Management first reported a position in DMK in Q4 2013 and held it in 5 quarters. The position peaked at $799K in Q4 2013. 58 funds tracked by Wall St. Rank hold DMK as of Q4 2017.

  • DAFNA Capital Management reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q4 2017 after selling out during the quarter.
  • DAFNA Capital Management sold 349 DMK Pharmaceuticals Corporation Common Stock shares in Q4 2017, an estimated $127K.
  • DAFNA Capital Management first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q4 2013 and held it in 5 quarters.
  • DAFNA Capital Management's DMK Pharmaceuticals Corporation Common Stock position peaked at $799K in Q4 2013.
  • 58 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q4 2017.

Based on DAFNA Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.